This guideline is the basis of QS16.
Ov Overview erview
This guideline covers managing hip fracture in adults. It aims to improve care from the time people aged 18 and over are admitted to hospital through to when they return to the community.
Recommendations emphasise the importance of early surgery and coordinating care through a multidisciplinary hip fracture programme to help people recover faster and regain their mobility.
NICE has also produced a guideline on osteoporosis: assessing the risk of fragility fracture.
In April 2017, we reviewed the evidence for the management of intracapsular hip fracture and changed recommendations 1.6.2 and 1.6.3 to emphasise the role of total hip replacement.
Who is it for?
Healthcare professionals
Commissioners and providers

Adults with hip fracture and their families and carers
Hip fracture: management (CG124)
Recommendations Recommendations
People have the right to be involved in discussions and make informed decisions about their care, as described in your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.
The following guidance is based on the best available evidence. The full guideline and addendum give details of the methods and the evidence used to develop the guidance.
Some aspects of hip fracture management are already covered by NICE guidance and are therefore outside the scope of this guideline. To ensure comprehensive management and continuity, the following NICE guidance should be referred to when developing a complete programme of care for each patient: technology appraisals guidance on osteoporotic fragility fracture prevention (denosumab for the prevention of osteoporotic fractures in postmenopausal women; and the following medicines for the primary and secondary prevention of osteoporotic fragility fractures in postmenopausal women: alendronate, etidronate, risedronate, raloxifene and strontium ranelate, and also teriparatide for secondary prevention); and clinical guidelines on falls, pressure ulcers, nutrition support, dementia, surgical site infection, venous thromboembolism, delirium and osteoporosis: assessing the risk of fragility fracture.
Imaging options in occult hip fracture
Offer magnetic resonance imaging (MRI) if hip fracture is suspected despite negative X-rays of the hip of an adequate standard. If MRI is not available within 24 hours or is contraindicated, consider computed tomography (CT). [2011, [2011, amended 2014] Offer total hip replacement rather than hemiarthroplasty to patients with a displaced intracapsular hip fracture who:
were able to walk independently out of doors with no more than the use of a stick and and are not cognitively impaired and and Use cemented implants in patients undergoing surgery with arthroplasty [1] .
[2011] [2011] 1.6.6
Consider an anterolateral approach in favour of a posterior approach when inserting a hemiarthroplasty. [2011] [2011] 1.6.7 Use extramedullary implants such as a sliding hip screw in preference to an intramedullary nail in patients with trochanteric fractures above and including the lesser trochanter (AO classification types A1 and A2). [2011] [2011] 1.6.8 Use an intramedullary nail to treat patients with a subtrochanteric fracture.
[2011] [2011] 1.7 Mobilisation strategies
Offer patients a physiotherapy assessment and, unless medically or surgically contraindicated, mobilisation on the day after surgery. [2011] [2011] 1.7.2 Offer patients mobilisation at least once a day and ensure regular physiotherapy review. [2011] [2011] 1.8 Multidisciplinary management The Association of Anaesthetists of Great Britain and Ireland, British Orthopaedic Association and British Geriatric Society have produced a safety guideline on reducing the risk from cemented hemiarthroplasty for hip fracture (2015) . This safety guideline is not NICE accredited.
De Dev velop an action plan
elop an action plan, with the steps needed to put the guideline into practice, and make sure it is ready as soon as possible. Big, complex changes may take longer to implement, but some may be quick and easy to do. An action plan will help in both cases.
6. F For v or very big changes ery big changes include milestones and a business case, which will set out additional costs, savings and possible areas for disinvestment. A small project group could develop the action plan.
The group might include the guideline champion, a senior organisational sponsor, staff involved in the associated services, finance and information professionals.
7. Implement the action plan Implement the action plan with oversight from the lead and the project group. Big projects may also need project management support.
8. Re Review and monitor view and monitor how well the guideline is being implemented through the project group.
Share progress with those involved in making improvements, as well as relevant boards and local partners.
NICE provides a comprehensive programme of support and resources to maximise uptake and use of evidence and guidance. See our into practice pages for more information. Hip fracture is a major public health issue due to an ever increasing ageing population. About 65,000 hip fractures occur each year and the annual cost (not including the considerable cost of social care) for all UK hip fracture cases is about £1 billion. About 10% of people with a hip fracture die within 1 month and about one-third within 12 months. Most of the deaths are due to associated conditions and not to the fracture itself, reflecting the high prevalence of comorbidity. Because the occurrence of fall and fracture often signals underlying ill health, a comprehensive multidisciplinary approach is required from presentation to subsequent follow-up, including the transition from hospital to community.
This guideline covers the management of hip fracture from admission to secondary care through to final return to the community and discharge from specific follow-up. It assumes that anyone clinically suspected of having a hip fracture will normally be referred for immediate hospital assessment. It excludes (other than by cross-reference) aspects covered by parallel NICE guidance, most notably primary and secondary prevention of fragility fractures, but recognises the importance of effective linkage to these closely related elements of comprehensive care. Although hip fracture is predominantly a phenomenon of later life (the National Hip Fracture Database reports the average age of a person with hip fracture as 84 years for men and 83 for women), it may occur at any age in people with osteoporosis or osteopenia, and this guidance is applicable to adults across the age spectrum. Management of hip fracture has improved through the research and reporting of key skills, especially by collaborative teams specialising in the care of older people (using the general designation 'orthogeriatrics'). These skills are applicable in hip fracture irrespective of age, and the guidance includes recommendations that cover the needs of younger patients by drawing on such skills in an organised manner.
Although not a structured service delivery evaluation, the Guideline Development Group was required to extend its remit to cover essential implications for service organisation within the NHS where these are fundamental to hip fracture management, and this has been done.
The NICE surveillance review identified new studies that were consistent with the current recommendations. However, because of a low level of compliance (around 30% nationally) with the recommendation to offer total hip replacement to people with displaced intracapsular hip fractures, we have updated this part of the guideline. The 2017 update also covers interventions for undisplaced intracapsular hip fractures, which were not covered in the original guideline.
The guideline will assume that prescribers will use a drug's summary of product characteristics to inform decisions made with individual patients.
More information
You can also see this guideline in the NICE Pathway on hip fracture.
To find out what NICE has said on topics related to this guideline, see our web page on trauma.
See also the guideline committee's discussion and the evidence reviews (in the full guideline and addendum), and information about how the guideline was developed, including details of the committee.
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In 2011 the guideline committee made the following recommendations for research. The committee's full set of research recommendations is detailed in the full guideline.
As part of the 2017 update, the standing committee removed the research recommendation on displaced intracapsular hip fractures and made an additional research recommendation on undisplaced intracapsular hip fractures. It is listed here and full details can be found in the addendum.
Imaging options in occult hip fracture
In patients with a continuing suspicion of a hip fracture but whose radiographs are normal, what is the clinical and cost effectiveness of computed tomography (CT) compared to magnetic resonance imaging (MRI), in confirming or excluding the fracture?
Wh Why this is important y this is important
The Guideline Development Group's consensus decision to recommend CT over a radionuclide bone scan as an alternative to MRI to detect occult hip fractures reflects current NHS practice but assumes that advances in technology have made the reliability of CT comparable with that of MRI.
If modern CT can be shown to have similar reliability and accuracy to MRI, then this has considerable implications because of its widespread availability out of hours and lower cost. It is therefore a high priority to confirm or refute this assumption by direct randomised comparison.
The study design would need to retain MRI as the 'gold standard' for cases of uncertainty and to standardise the criteria, expertise and procedures for radiological assessment. Numbers required would depend on the degree of sensitivity and specificity (the key outcome criteria) set as target requirement for comparability, but need not necessarily be very large. [2011] [2011] 2 Anaesthesia
What is the clinical and cost effectiveness of regional versus general anaesthesia on postoperative morbidity in patients with hip fracture?
No recent randomised controlled trials were identified that fully address this question. The evidence is old and does not reflect current practice. In addition, in most of the studies the patients are sedated before regional anaesthesia is administered, and this is not taken into account when
Hip fracture: management (CG124) analysing the results. The study design for the proposed research would be best addressed by a randomised controlled trial. This would ideally be a multi-centre trial including 3000 participants in each arm. This is achievable given that there are about 70,000 to 75,000 hip fractures a year in the UK. The study should have three arms that look at spinal anaesthesia versus spinal anaesthesia plus sedation versus general anaesthesia; this would separate those with regional anaesthesia from those with regional anaesthesia plus sedation. The study would also need to control for surgery, especially type of fracture, prosthesis and grade of surgeon.
A qualitative research component would also be helpful to study patient preference for type of anaesthesia. [2011] [2011] 3 Undisplaced intracapsular hip fractures The committee also noted a paucity of evidence for 2 of the interventions (total hip replacement and hemiarthroplasty) that could potentially be useful for people with undisplaced intracapsular hip fracture. A randomised controlled trial comparing these interventions would be beneficial.
[2017] [2017] 4 Intensive rehabilitation therapies after hip fracture
What is the clinical and cost effectiveness of additional intensive physiotherapy and/or occupational therapy (for example progressive resistance training) after hip fracture?
The rapid restoration of physical and self care functions is critical to recovery from hip fracture, particularly where the goal is to return the patient to preoperative levels of function and residence.
Approaches that are worthy of future development and investigation include progressive resistance training, progressive balance and gait training, supported treadmill gait re-training, dual task training, and activities of daily living training. The optimal time point at which these interventions should be started requires clarification.
The ideal study design is a randomised controlled trial. Initial studies may have to focus on proof of concept and be mindful of costs. A phase III randomised controlled trial is required to determine clinical effectiveness and cost effectiveness. The ideal sample size will be around 400 to 500 patients, and the primary outcome should be physical function and health-related quality of life.
Outcomes should also include falls. A formal sample size calculation will need to be undertaken. 
Early supported discharge in care home patients
What is the clinical and cost effectiveness of early supported discharge on mortality, quality of life and functional status in patients with hip fracture who are admitted from a care home?
Wh Why this is important y this is important
Residents of care and nursing homes account for about 30% of all patients with hip fracture admitted to hospital. Two-thirds of these come from care homes and the remainder from nursing homes. These patients are frailer, more functionally dependent and have a higher prevalence of cognitive impairment than patients admitted from their own homes. One-third of those admitted from a care home are discharged to a nursing home and one-fifth are readmitted to hospital within 3 months. There are no clinical trials to define the optimal rehabilitation pathway following hip fracture for these patients and therefore represent a discrete cohort where the existing metaanalyses do not apply. As a consequence, many patients are denied structured rehabilitation and are discharged back to their care home or nursing home with very little or no rehabilitation input.
Given the patient frailty and comorbidities, rehabilitation may have no effect on clinical outcomes for this group. However, the fact that they already live in a home where they are supported by trained care staff clearly provides an opportunity for a systematic approach to rehabilitation. Early multidisciplinary rehabilitation based in care homes or nursing homes would take advantage of the Hip fracture: management (CG124) day-to-day care arrangements already in place and provide additional NHS support to deliver naturalistic rehabilitation, where problems are tackled in the patient's residential setting.
Early supported multidisciplinary rehabilitation could reduce hospital stay, improve early return to function, and affect both readmission rates and the level of NHS-funded nursing care required.
The research would follow a two-stage design: (1) an initial feasibility study to refine the selection criteria and process for reliable identification and characterisation of those considered most likely to benefit, together with the intervention package and measures for collaboration between the Hip Fracture Programme team, care-home staff and other community-based professionals, and (2) a cluster randomised controlled comparison (for example, with two or more intervention units and matched control units) set against agreed outcome criteria. The latter should include those specified above, together with measures of the impact on care-home staff activity and cost, as well as qualitative data from patients on relevant quality-of-life variables. [2011] [2011]
